Health Condition 1: - Health Condition 2: L63- Alopecia areata
Conditions
Interventions
Intervention1: Intralesional Methotrexate: I/L Methotrexate (25mg/ml )
(Max.dose-5mg)
sessions will be repeated every 3 weeks for maximum three sessions and patients will be assessed on each f
Sponsors
Karthiyaini A
Eligibility
Inclusion criteria
Inclusion criteria: 1.Adult patients with Localized Alopecia Areata of the scalp with = 3 patches 2.Patients who did not receive any specific treatment for Alopecia Areata or regrowth of hair during the last 3 months.
Exclusion criteria
Exclusion criteria: 1.Pregnant and lactating women 2.Chronic hepatic or hematological disorders 3.Patients on systemic corticosteroids or other Immunosuppressants 4.Local infections
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Compare the effectiveness of Intralesional Methotrexate and Intralesional Triamcinolone Acetonide in the treatment of localized Alopecia areata of the scalp clinically using SALT score and Regrowth scale. Timepoint: Sessions will be repeated every 3 weeks for maximum three sessions(0,3,6weeks) and patient will be evaluated at 9th week and12th week. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the Trichoscopic changes following treatment of localized alopecia areata of scalp with Intralesional Methotrexate & Intralesional Triamcinolone Acetonide.Timepoint: Sessions will be repeated every 3 weeks for maximum three sessions(0,3,6weeks) & patient will be evaluated at 9th week and12th week. | — |
Countries
India
Contacts
Public ContactKARTHIYAINI A
Aarupadai Veedu medical college and hospital,Pondicherry
Outcome results
None listed